Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -66,246 | -61,376 | -8,943 | N/A |
| Depreciation Amortization | 4,834 | 4,932 | 5,661 | N/A |
| Accounts receivable | -6,815 | -409 | 4,691 | N/A |
| Other Working Capital | -11,124 | 7,998 | 7,881 | N/A |
| Other Operating Activity | 19,141 | 35,864 | -3,466 | 0 |
| Operating Cash Flow | $-60,210 | $-12,991 | $5,824 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -663 | -1,824 | -2,068 | N/A |
| Investing Cash Flow | $-663 | $-1,824 | $-2,068 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 70,000 | N/A | 5,000 | N/A |
| Debt Repayment | -52,944 | 0 | N/A | N/A |
| Common Stock Issued | 39,317 | 68,830 | 24 | N/A |
| Other Financing Activity | -6,773 | -10,795 | -610 | 0 |
| Financing Cash Flow | $49,600 | $58,035 | $4,414 | $N/A |
| Beginning Cash Position | 60,599 | 17,379 | 9,209 | N/A |
| End Cash Position | 49,326 | 60,599 | 17,379 | N/A |
| Net Cash Flow | $-11,273 | $43,220 | $8,170 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -60,210 | -12,991 | 5,824 | N/A |
| Capital Expenditure | -663 | -1,824 | -2,068 | N/A |
| Free Cash Flow | -60,873 | -14,815 | 3,756 | 0 |